Profile
ExSight Ventures is a venture capital firm based in the United States, specializing in early-stage investments in the life sciences sector, particularly in ophthalmic companies. The firm was founded by two accomplished retinal surgeons who leverage their in-depth knowledge and networks within the field to guide investment decisions. ExSight Ventures is noted for its strategic focus on ophthalmology, differentiating itself through a combination of domain-specific expertise and a mission-focused approach to investing in innovative diagnostic and treatment solutions for eye conditions.
The firm invests in biotechnology, medical devices, pharmaceuticals, and software that have applications within ophthalmology. ExSight Ventures targets investment rounds from pre-seed to Series B, where its capital, along with advisory and industry insights, can significantly impact the development and success of its portfolio companies. The firm's commitment to early-stage life sciences is complemented by its capital-efficient investment strategies, aimed at maximizing value creation. The firm does not have a public record of total AUM or detailed fund histories available.
Notable portfolio companies of ExSight Ventures include a selection focused on vision and ophthalmology-related breakthroughs. Due to the firm's concentrated focus, these companies typically reflect innovative advancements within the sector, although specific company names were not prominently listed on the website.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.